Immunotherapy in triple-negative breast cancer: A literature review and new advances GA Valencia, P Rioja, Z Morante, R Ruiz, H Fuentes, CA Castaneda, ... World Journal of Clinical Oncology 13 (3), 219, 2022 | 23 | 2022 |
Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy L Carril-Ajuria, D Lora, A Carretero-González, M Martín-Soberón, ... Clinical genitourinary cancer 19 (2), 95-102, 2021 | 12 | 2021 |
Epidemiology of thymic epithelial tumors: 22‐years experience from a single‐institution P Rioja, R Ruiz, M Galvez‐Nino, S Lozano, N Valdiviezo, M Olivera, ... Thoracic cancer 12 (4), 420-425, 2021 | 5 | 2021 |
Characteristics and outcomes of thymomas in L atin A merica: Results from over 10 years of experience (CLICaP‐LATimus) C Martín, D Enrico, L Mas, AK Patane, O Arrieta, T Soria, AF Cardona, ... Thoracic cancer 12 (9), 1328-1335, 2021 | 4 | 2021 |
Renal liposarcoma: case report and review of systemic treatment P Rioja, G Valencia, C Centurión-Rodriguez, Z Morante, M Bravo, ... ecancermedicalscience 15, 2021 | 3 | 2021 |
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report GA Valencia, P Rioja, Z Morante, JM Araujo, HD Vallejos, H Guerra, ... World Journal of Clinical Oncology 12 (8), 702, 2021 | 2 | 2021 |
New prognostic classification for adult T cell lymphoma/leukemia based on hypercalcemia and neutrophil-to-lymphocyte ratio DJ Enriquez, JC Haro, P Rioja, G De La Cruz, Z Morante, C Barrionuevo, ... Blood 130, 4164, 2017 | 2 | 2017 |
COVID-19 pandemic impact on the oncology care using a virtual survey in Peru. G Valencia, D Enriquez, P Rioja, L Lachira, M Calderon, ... Journal of Clinical Oncology 41 (16_suppl), e18738-e18738, 2023 | 1 | 2023 |
The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems G Valencia-Mesías, P Rioja-Viera, Z Morante-Cruz, Y Toledo-Morote, ... ecancermedicalscience 15, 2021 | 1 | 2021 |
P1. 10 Survival of Thymoma Is Extensive in Latin-American Patients: Results from over 10 Years of Experience (CLICaP-LATimus) L Mas, AK Patane, O Arrieta, T Soria, AF Cardona, C Martín, ... Journal of Thoracic Oncology 14 (11), S1177-S1178, 2019 | 1 | 2019 |
PO105 TREATMENT SEQUENCING AND OVERALL SURVIVAL OF HER2-POSITIVE ADVANCED BREAST CANCER IN A PERUVIAN INSTITUTION G Valencia, P Rioja, O Peralta, M Chirito, Z Morante, H Fuentes, ... The Breast 71, S50-S51, 2023 | | 2023 |
Quality of life during medical oncological treatment in a real-world study in a single-institution of Peru. P Rioja, G Valencia, JM Araujo, JA Pinto, A Godenzi, B Neciosup, ... Journal of Clinical Oncology 41 (16_suppl), e18735-e18735, 2023 | | 2023 |
Testicular GERM cell tumors treatment outcome in a national cancer institution in Peru. P Rioja, G Valencia, Z Morante, H Fuentes, R Mantilla, ... Journal of Clinical Oncology 41 (16_suppl), e17031-e17031, 2023 | | 2023 |
Real-world genetic testing patterns in metastatic prostate cancer in Latin American (LATAM) population. M Angel, B Freile, A Rodriguez, F Cayol, R Manneh Kopp, P Rioja, ... Journal of Clinical Oncology 41 (16_suppl), e17055-e17055, 2023 | | 2023 |
Implementation of a comprehensive companion program for patients undergoing systemic cancer treatment. P Rioja, R Ruiz, J Macetas, S Acevedo, T Guevara, MR Quesquen, ... Journal of Clinical Oncology 41 (16_suppl), e18631-e18631, 2023 | | 2023 |
Real-world efficacy of nivolumab in Peruvian patients with advanced melanoma. K Roque, G Valencia, P Rioja, A huaman Campos, V Colomo Costas, ... Journal of Clinical Oncology 41 (16_suppl), e18849-e18849, 2023 | | 2023 |
Zaida Morante1, 2, Yomali Ferreyra3, Joseph A. Pinto4, Natalia Valdivieso1, Carlos Castañeda1, Tatiana Vidaurre1, Guillermo Valencia1, Patricia Rioja1, Hugo Fuentes1, Jose M … N Valdivieso, C Castañeda, T Vidaurre, G Valencia, P Rioja, H Fuentes, ... | | 2023 |
Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in … Z Morante, Y Ferreyra, JA Pinto, N Valdivieso, C Castañeda, T Vidaurre, ... Frontiers in Oncology 13, 2023 | | 2023 |
Latest advances in neoadjuvant therapy for bladder cancer. P Rioja, G Valencia, Z Morante, R Paz, H Vallejos, H Fuentes, S Neciosup | | 2022 |
A prognostic model for distant recurrence-free survival in triple-negative breast cancer (TNBC) and the outcomes of initiation of adjuvant chemotherapy in the risk of relapse. Z Morante, Y Ferreyra, J Pinto, G Valencia, PE RiojaViera, H Fuentes, ... Journal of Clinical Oncology 40 (16_suppl), 530-530, 2022 | | 2022 |